Cancer Incidence in Nigeria and Border Countries
DOI:
https://doi.org/10.18034/mjmbr.v5i1.442Keywords:
Globocan, Nigeria, border countries, incidence, percentagesAbstract
Many inequalities in cancer incidence exist between Nigeria and border countries. This information is absent or largely unavailable.
Benin, Cameroun, Chad, Niger, and Nigeria cover a population of more than 224,922,000. Globocan data base supplied incidence for 132,939cases of cancer for these countries. The prevalence of Bladder, Colorectum, Kaposi sarcoma, Larynx, Leukaemia, Lip, oral cavity, Liver, Lungwas estimated for the year 2012.The prevalence of Nasopharynx, Non – Hodgkin, Lymphoma, Pancrease, Prostrate, Stomach combined was also estimated for the same year.
The most common male cancer found in Nigeria and border countries is Prostate cancer, seconded by Liver. In this study also we found Breast cancer to be the most common in females, followed by Cervical Cancer. Larynx and Kaposi sarcoma are found to be the least common cancer for both males and females in the population.
In conclusion, the findings of this study gave lights to some guidelines to aid the design of cancer control programs in Nigeria and border countries. The spectrum of the cancers is dominated by the breast & Cervix uteri for females, while Prostate & Liver for males.
Downloads
References
Ahmed Jemal, DVM, Freddie Bray, David Forman, et al. Cancer Burden in Africa and Opportunities for Prevention. Surveillance Research Program, American Cancer Society 2011. Published by Wiley Online Library
Ahmed Jemal, DVM, Freddie Bray, Melissa M. Center, et al. Global Cancer Statistics. CA Cancer J Clin. 2011; 61: 69 – 90
Akinde OR, Phillips AA, Oguntunde OA, Afolayan OM. Cancer Mortality Pattern in Lagos University Teaching Hospital, Lagos, Nigeria. Journal of Cancer Epidemiology 2015, 842032 – 8
AN Fiander. The Prevention of Cervical Cancer in Africa. Future Medicine 2011, Vol 7, 1: 121 – 132
Boyle P, Levin B. World Cancer Report 2008. Lyon, France: International Agency for Research on Cancer, 2008
Elima Jedy – Agba, Maria Paula Curado, OlufemiOgunbiyi, et al. Cancer Incidence in Nigeria: A report from Population – Based Cancer Registries 2012. CANEP – 437, 8p
Ferlay J. Shin HR, Bray F. Forman D. Mathers, C. Parkin DM. Estimates of Worldwide Burden of Cancer in 2008; Globocan 2008. Int J. Cancer 2010;127:2893-917
Hsing AW, Yeboah E, Biritwum R, et al. High Prevalence of Screen Detected Prostrate Cancer in West Africans: Implications for Racial Disparity of Prostrate Cancer. J Urol. 2014 Sep; 192(3): 730 – 5
Iseh KR, Abdullahi M, Aliyu D; Laryngeal Tumors: Clinical Pattern in Sokoto, North - Western, Nigeria, Nig journal of medicine, vol. 20, No.1.2011.
Jamison DT, Feachem RG, Magkoba MW, et al. Disease and Mortality in Sub – Saharan Africa, 2nd Edition. World Bank; 2006
Krown SE. Treatment strategies for Kaposi Sarcoma in Sub-Saharan Africa: Challenges and Opportunities. CurrOpin Oncol. 2011 Sept; 23(5): 463 – 8.
Lisa W. Chu, Jamie Ritchey, Susan S. Devesa, Sabah M. Quraishi, Hongmei Zhang, and Ann W. Hsing.Prostate Cancer Incidence Rates in Africa.HindawiPublshing Corporation 2011; 2011: 6p
Mbakop A, Essame Oyono JL, Ngbangako MC, Abondo A. Current Epidemiology of Cancers in Cameroun ( Central Africa). Bull Cancer, 1992; 79 (11): 1101 – 4
Mohammed AZ, Edino ST, Ochicha O, et al. Cancer in Nigeria: A 10 – Year Analysis of the Kano Cancer Registry. Nige Journal of Medicine, Vol. 17. No 3. July – August 2008.
Parkin DM. Global Cancer Statistics in the Year 2000. Lancet Oncol 2001;2:533
Samuel W.B., Marshall M., Roy R.C. Laryngeal cancer, www.health.am/cr/laryngeal- cancer.
Z. Sando, Y. F. Fouelifack, T. J. Fouogue, et al. Trends in Breast and Cervical Cancer Incidence in Cameroun (Central Africa) from 2004 to 2011. African Journal of Cancer; Online ISSN 1965 – 0825
-- 0 --